Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.
Click on title to sort | Dec 2020 | Dec 2021 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AUROBINDO PHARMA | 63,649 | 29,624 | 60,022 | 6,114 | -5.7% | -79.4% | 15.3 | More Info
|
AUROBINDO PHARMA | 63,649 | 29,624 | 60,022 | 6,114 | -5.7% | -79.4% | 15.3 | More Info
|
AUROBINDO PHARMA | 63,649 | 29,624 | 60,022 | 6,114 | -5.7% | -79.4% | 15.3 | More Info
|
AUROBINDO PHARMA | 63,649 | 29,624 | 60,022 | 6,114 | -5.7% | -79.4% | 15.3 | More Info
|
BIOCON | 18,574 | 1,877 | 21,742 | 2,668 | 17.1% | 42.1% | 29.4 | More Info
|
BIOCON | 18,574 | 1,877 | 21,742 | 2,668 | 17.1% | 42.1% | 29.4 | More Info
|
CIPLA | 51,687 | 7,525 | 54,789 | 7,590 | 6.0% | 0.9% | 15.2 | More Info
|
CIPLA | 51,687 | 7,525 | 54,789 | 7,590 | 6.0% | 0.9% | 15.2 | More Info
|
CIPLA | 51,687 | 7,525 | 54,789 | 7,590 | 6.0% | 0.9% | 15.2 | More Info
|
DIVIS LABORATORIES | 17,014 | 4,706 | 24,932 | 9,022 | 46.5% | 91.7% | 53.8 | More Info
|
DIVIS LABORATORIES | 17,014 | 4,706 | 24,932 | 9,022 | 46.5% | 91.7% | 53.8 | More Info
|
GLENMARK PHARMA | 27,868 | 2,482 | 31,734 | 2,398 | 13.9% | -3.4% | N.A. | More Info
|
LUPIN | 40,174 | 4,412 | 41,609 | 5,491 | 3.6% | 24.5% | 18.4 | More Info
|
LUPIN | 40,174 | 4,412 | 41,609 | 5,491 | 3.6% | 24.5% | 18.4 | More Info
|
LUPIN | 40,174 | 4,412 | 41,609 | 5,491 | 3.6% | 24.5% | 18.4 | More Info
|
PIRAMAL ENTERPRISES | 31,686 | 6,520 | 22,852 | 5,815 | -27.9% | -10.8% | N.A. | More Info
|
SUN PHARMA | 88,368 | 19,181 | 98,631 | 21,308 | 11.6% | 11.1% | 13.0 | More Info
|
SUN PHARMA | 88,368 | 19,181 | 98,631 | 21,308 | 11.6% | 11.1% | 13.0 | More Info
|
ZYDUS LIFESCIENCES | 36,330 | 4,859 | 36,398 | 4,948 | 0.2% | 1.8% | 11.4 | More Info
|
ZYDUS LIFESCIENCES | 36,330 | 4,859 | 36,398 | 4,948 | 0.2% | 1.8% | 11.4 | More Info
|
Sector Aggregate | 910,304 | 224,554 | 947,275 | 147,800 | 4.1% | -34.2% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |
Sep 2021 Results | Mar 2022 Results | Latest Quarter Results | View All Results |